Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent expiration for Novartis drug PROMACTA KIT appeared f…
New patent expiration for Novartis drug PROMACTA KIT Read Post »
PROMACTA (eltrombopag olamine) Novartis Patent: 7,452,874 Expiration: Nov 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug…
Drug Patent Expirations for the Week of November 21, 2021 Read Post »
Annual Drug Patent Expirations for TYKERB Tykerb is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent expiration for Novartis drug TYKERB appeared first on D…
Annual Drug Patent Expirations for ROZEREM Rozerem is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Takeda Pharms drug ROZEREM appeared first on Drug…
New patent expiration for Takeda Pharms drug ROZEREM Read Post »
ASACOL HD (mesalamine) Apil Patent: 9,089,492 Expiration: Nov 15, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expi…
Drug Patent Expirations for the Week of November 14, 2021 Read Post »
Annual Drug Patent Expirations for ASACOL+HD Asacol Hd is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for APIL drug ASACOL HD appeared first on DrugPate…
Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. This drug has one…
The post New patent expiration for Novartis drug AMTURNIDE appeared first o…
New patent expiration for Novartis drug AMTURNIDE Read Post »
ASACOL HD (mesalamine) Apil Patent: 9,089,492 Expiration: Nov 15, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent Expi…
Drug Patent Expirations for the Week of November 14, 2021 Read Post »
Annual Drug Patent Expirations for EOVIST Eovist is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Bayer Hlthcare drug EOVIST appeared first on Dr…
New patent expiration for Bayer Hlthcare drug EOVIST Read Post »
Annual Drug Patent Expirations for BROVANA Brovana is a drug marketed by Sunovion and is included in one NDA. It is available from two suppliers. There are eleven patents protecting…
The post New patent expiration for Sunovion drug BROVANA appeared fir…